INTUITIVE SURGICAL INC's gross profit margin for the fourth quarter of its fiscal year 2015 is essentially unchanged when compared to the same period a year ago. The company has grown its sales and net income during the past quarter when compared with the same quarter a year ago, and although its growth in net income has outpaced the industry average, its revenue growth has not. INTUITIVE SURGICAL INC is extremely liquid. Currently, the Quick Ratio is 4.01 which clearly shows the ability to cover any short-term cash needs. ISRG managed to increase the liquidity from the same period a year ago, despite already having very strong liquidity to begin with. This would indicate improved cash flow.
At the same time, stockholders' equity ("net worth") has greatly increased by 27.81% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY15||Q4 FY14|
|Net Sales ($mil)||676.5||604.7|
|Net Income ($mil)||190.0||146.8|
|Balance Sheet||Q4 FY15||Q4 FY14|
|Cash & Equiv. ($mil)||1559.8||1232.5|
|Total Assets ($mil)||4907.3||3959.4|
|Total Debt ($mil)||0.0||0.0|
|Profitability||Q4 FY15||Q4 FY14|
|Gross Profit Margin||70.86||68.41|
|Return on Assets||11.99||10.57|
|Return on Equity||13.63||12.39|
|Debt||Q4 FY15||Q4 FY14|
|Share Data||Q4 FY15||Q4 FY14|
|Shares outstanding (mil)||37.4||36.6|
|Div / share||0.0||0.0|
|Book value / share||115.49||92.33|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||368461.0||323725.0|
BUY. The current P/E ratio indicates a significant discount compared to an average of 52.05 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 20.44. Conducting a second comparison, its price-to-book ratio of 4.39 indicates a significant premium versus the S&P 500 average of 2.43 and a premium versus the industry average of 3.72. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium.
|ISRG 32.69||Peers 52.05||ISRG 24.58||Peers 23.49|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
ISRG is trading at a significant discount to its peers.
Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
ISRG is trading at a valuation on par to its peers.
|ISRG 21.99||Peers 19.74||ISRG 0.99||Peers 1.60|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
ISRG is trading at a premium to its peers.
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
ISRG trades at a significant discount to its peers.
|ISRG 4.39||Peers 3.72||ISRG 38.69||Peers -9.89|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
ISRG is trading at a premium to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
ISRG is expected to have an earnings growth rate that significantly exceeds its peers.
|ISRG 7.96||Peers 5.87||ISRG 11.85||Peers 18.49|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
ISRG is trading at a significant premium to its industry.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
ISRG significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.